Medtronic (MDT) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Medtronic (MDT)

MDT 89.31

-1.5%

9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dennis who wrote (676)	12/27/2004 10:53:07 AM
From: Jack Hartmann	Read Replies (1) of 687

MDT Medtronic undervalued - Barron's (48.14 ) Barron's highlights Medtronic, which is undervalued and should profit from growing defibrillator mkt. J&J is spending $25 bn for Guidant, mainly to get into the mkt. J&J clearly stands among those who believe that the $5 bn defibrillator mkt is one of health care's big growth opportunities. Even so, investors seem to harbor doubt about Medtronic. Its shares have slipped from $54 to $48 in the last month. In fact, after decades as a growth stock that even a conservative investor could own, Medtronic shares have been convalescing between 40 and 50 bucks for most of the past 4 years. Yet Medtronic has several opportunities to quicken interest in its shares. The co trades at 23x next year's projected earnings, compared with roughly 30x earnings for defibrillator rivals Guidant and St. Jude Medical. If the defibrillator mkt stays s

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next